Emergence of Clinically Macrolide-Unresponsive Mycoplasma pneumoniae Segmental/Lobar Pneumonia and COVID-19 Pneumonia in Children in Taiwan, 2024–2025
Antibiotics · 13.03.2026 · 15 (3) · 292
DOI: 10.3390/antibiotics15030292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 13.03.2026. Verfasst von Hao-Yuan Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 35664, Taiwan. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wei Gong Memorial Hospital.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
To date, no study has compared the clinical characteristics of Mycoplasma pneumoniae-associated segmental/lobar pneumonia, Mycoplasma bronchopneumonia, and COVID-19 pneumonia primarily caused by the NB.1.8.1 variant in children.
Methods
We examined the epidemiologic trends of pneumonia, segmental/lobar pneumonia, and COVID-19 pneumonia at a teaching hospital from 2015 to 2025. In addition, we compared the clinical characteristics of children hospitalized with Mycoplasma segmental/lobar pneumonia, Mycoplasma bronchopneumonia, and COVID-19 pneumonia during the NB.1.8.1 variant wave in 2024–2025.
Results
Between 2015 and 2024, 10,601 pneumonia cases were identified, including 525 cases of segmental/lobar pneumonia and 162 cases of COVID-19 pneumonia. An outbreak of segmental/lobar M. pneumoniae pneumonia and COVID-19 pneumonia occurred in Taiwan during 2024–2025. Starting in early 2025, monthly Mycoplasma positivity rates among children with segmental/lobar pneumonia and bronchopneumonia exceeded 60%. Mycoplasma pneumonia predominantly affected children aged 6–11 years, whereas COVID-19 pneumonia mainly occurred in those younger than 3 years of age. Fever, cough, and rhinorrhea were the most common symptoms in all groups, limiting clinical differentiation. Children with segmental/lobar Mycoplasma pneumonia were more likely to present with prolonged fever (>5 days), lymphocytopenia, a neutrophil-to-lymphocyte ratio (NLR) ≥ 3, and elevated C-reactive protein (CRP) levels, each of which was strongly associated with macrolide non-response (all p < 0.001).
Conclusions
Children with segmental/lobar Mycoplasma pneumonia demonstrated more severe clinical manifestations. Segmental/lobar involvement and inflammatory markers, such as lymphocytopenia, elevated NLR, and increased CRP levels, were associated with macrolide non-response. These indicators may help guide therapeutic decision-making in pediatric M. pneumoniae pneumonia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 35664, Taiwan.
- Department of Pediatrics, Wei Gong Memorial Hospital, Miaoli 35159, Taiwan.
- School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei 242062, Taiwan.
- Division of Pediatric Infectious Diseases, China Medical University Children's Hospital, China Medical University, Taichung 40447, Taiwan.
- Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan.
- Department of Neurosurgery, China Medical University Children's Hospital, China Medical University, Taichung 40447, Taiwan.
ORCID-Profile: Hao-Yuan Lee, Shu-Hua Ko
Förderung
- Wei Gong Memorial Hospital
Zitieren
APA
Lee, H. Y., Chen, C. C., Ko, S. H., Huang, Y. L., Chang, E. P., Hsu, C. Y., Wu, J. R., Chen, W. H., Hsu, Y. C., Li, M. Y., Hsu, Y. L., Lee, W. Y., & Chen, C. L. (2026). Emergence of Clinically Macrolide-Unresponsive Mycoplasma pneumoniae Segmental/Lobar Pneumonia and COVID-19 Pneumonia in Children in Taiwan, 2024–2025. Antibiotics, 15(3), 292. https://doi.org/10.3390/antibiotics15030292
Vancouver
Lee HY, Chen CC, Ko SH, Huang YL, Chang EP, Hsu CY, et al. Emergence of Clinically Macrolide-Unresponsive Mycoplasma pneumoniae Segmental/Lobar Pneumonia and COVID-19 Pneumonia in Children in Taiwan, 2024–2025. Antibiotics. 2026;15(3):292. doi:10.3390/antibiotics15030292
BibTeX
@article{Lee2026,
author = {Lee, Hao-Yuan and Chen, Chien-Chin and Ko, Shu-Hua and Huang, Yu-Ling and Chang, En-Pen and Hsu, Cheng-Yi and Wu, Jia Ru and Chen, Wei-Hsin and Hsu, Yu-Chau and Li, Meng-Yen and Hsu, Yu-Lung and Lee, Wen-Yuan and Chen, Chyi-Liang},
title = {Emergence of Clinically Macrolide-Unresponsive Mycoplasma pneumoniae Segmental/Lobar Pneumonia and COVID-19 Pneumonia in Children in Taiwan, 2024–2025},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {3},
pages = {292},
doi = {10.3390/antibiotics15030292}
}
EUVIMED